Avanos Medical (NYSE:AVNS) announced today that it appointed David Pacitti as its new CEO, effective April 14, 2025.

Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025.

An update from Avanos Medical ( ($AVNS) ) is now available. On March 17, 2025, Avanos Medical announced the appointment of David Pacitti as its ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

Siemens Healthineers’ president of the Americas, David Pacitti, is leaving the imaging giant to become CEO of the devicemaker ...

Abbott Laboratories engages in the discovery ... The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular ...

Cagent Vascular, Inc., the exclusive developer of serration technology for vessel dilation in endovascular interventions, ...

and Abbott (NYSE: ABT). With a proven track record of driving revenue growth, expanding market share, and fostering strategic partnerships, he will play a critical role in scaling Cagent Vascular ...